AUTHORS
Anusree Lohithakshan, PhD, Jiajing Qiu, PhD2, Mary Slavinsky, N/A3, Saghi Ghaffari Jr, MD PhD4
AFFILIATIONS
1 Icahn School of Medicine at Mount Sinai, New York, New York, United States
2 Icahn School of Medicine at Mount Sinai, New York, New York, United States
3 Icahn School of Medicine at Mount Sinai, New York, New York, United States
4 Icahn School of Medicine at Mount Sinai, New York, New York, United States, Icahn School of Medicine at Mount Sinai, New York, New York, United States, Icahn School of Medicine at Mount Sinai, New York, New York, United States
ABSTRACT
Quiescence is a fundamental property of hematopoietic stem cells (HSCs) that is paradoxically coupled with HSC potency and is essential to maintain hematopoietic homeostasis, yet the complex signaling network that regulates HSCs’ quiescence remains unclear. Lysosomes are critical regulators of HSC quiescence, and their relatively low degradative activity is essential for maintaining HSC potency, longevity, quiescence and fitness (Liang et al., Cell Stem Cell, 2020; Arif et al., Cell Stem Cell, 2025). As the primary degradative organelles of the cell, lysosomes rely on an acidic luminal pH (4.5-5) to support the optimal catalytic activity of their hydrolases. This acidic environment is established and maintained primarily by the ATP-driven multi-subunit complexes vacuolar H+-adenosine triphosphatase (v-ATPase), a proton pump localized to the lysosomal membrane. Notably, pharmacological inhibition of v-ATPase with Concanamycin A, reduces lysosomal activity, improves HSC quiescence, markedly enhances the functional potency of young HSCs, and restores youthful properties in aged HSCs (Liang et al., Cell Stem Cell, 2020; Arif et al., Cell Stem Cell, 2025).
The v-ATPase complex consists of two functional domains, the catalytic peripheral domain, V1 and the membrane embedded proton-translocating domain, V0. However, the role of v-ATPases in regulating HSC function and lysosomal activity remains largely unknown. To address this, we sought to identify v-ATPase subunits that are preferentially expressed in murine HSCs. Guided by our previously generated scRNA-seq data (Liang et al., Cell Stem Cell, 2020), we identified several v-ATPase subunits enriched in HSCs. Our immunofluorescent confocal microscopy analysis showed that the v-ATPase subunits V0A1, V0A2, V0A3, V1C1, and V1E1, are expressed in both quiescent and primed (activated) murine HSCs, with significantly higher levels of expression in primed HSCs under steady state conditions. V-ATPase subunits showed differential HSC localization and co-localization with lysosomal marker LAMP1, suggesting functional heterogeneity in their contributions to lysosomal acidification. Consistent with these findings using the Lysosensor Yellow/Blue-dextran (LSBY- dextran) assay – that we optimized for measuring HSCs’ lysosomal pH – we found that quiescent HSCs have lower lysosomal acidity (higher pH) than primed HSCs.
We previously showed that glycolysis is preferentially used by primed relative to quiescent HSCs, and that both glucose uptake and glycolytic flux are elevated in primed relative to quiescent HSCs in a lysosome-dependent manner (Liang et al., Cell Stem cell, 2020). To further investigate the function of v-ATPase during HSC activation, we stimulated HSCs with increasing concentrations of glucose (0.2-25 mM). Glucose stimulation increased the v-ATPase subunits’ expression while reducing lysosomal mass as measured by LAMP1, as well as the overall co-localization of v-ATPase with LAMP1. Notably, the LSBY- dextran assay showed that glucose stimulation enhanced lysosomal acidification in both quiescent and primed HSCs.
Next, we examined the status of Aldolase A, a glycolytic enzyme that directly interacts with a subset of v-ATPase subunits in a glucose-dependent manner. We found that glucose stimulation upregulated Aldolase A expression and enhanced its co-localization with v-ATPase subunit V0A3 in both quiescent and primed HSCs. However, despite glucose-induced changes in v-ATPase expression and lysosomal acidification, glucose stimulation did not improve lysosomal proteolytic activity as assessed by DQ-BSA assay, nor did it alter cell cycle entry, as determined by CDK6 expression and subcellular localization, in HSCs. Together, these ex vivo data suggest that glucose activates v-ATPase and promotes its regulation of lysosomal function in HSCs without inducing HSC activation. Consistent with our previous finding that glycolysis is dispensable for quiescent HSCs but supports the metabolic demands of primed HSCs (Liang et al., Cell Stem Cell, 2020), our results demonstrate that glucose primes lysosomal function for activation without directly driving HSC activation.
Collectively, our results suggest that targeting v-ATPase may provide a strategy to modulate HSC state and function through the regulation of lysosomal activity. Ongoing studies using knockdown of individual v-ATPase subunits are expected to further define the mechanisms by which v-ATPase regulate HSC function.
DISCLOSURES
Anusree Lohithakshan, PhD: No relevant conflicts of interest to declare.